Literature DB >> 27043088

Pulmonary hypertension in the premature infant: a challenging comorbidity in a vulnerable population.

Michael Glenn O'Connor1, David N Cornfield, Eric D Austin.   

Abstract

PURPOSE OF REVIEW: This review is written from the perspective of the pediatric clinician involved in the care of premature infants at risk for pulmonary hypertension. The main objective is to better inform the clinician in the diagnosis and treatment of pulmonary hypertension in premature infants by reviewing the available relevant literature and focusing on the areas for which there is the greatest need for continued research. RECENT
FINDINGS: Continued knowledge regarding the epidemiology of pulmonary hypertension in the premature infant population has aided better diagnostic screening algorithms. Included in this knowledge, is the association of pulmonary hypertension in infants with bronchopulmonary dysplasia (BPD). However, it is also known that beyond BPD, low birth weight and other conditions that result in increased systemic inflammation are associated with pulmonary hypertension. This information has led to the recent recommendation that all infants with BPD should have an echocardiogram to evaluate for evidence of pulmonary hypertension prior to discharge from the neonatal ICU.
SUMMARY: Pulmonary hypertension can be a significant comorbidity for premature infants. This review aims to focus the clinician on the available literature to improve recognition of the condition to allow for more timely interventions.

Entities:  

Mesh:

Year:  2016        PMID: 27043088      PMCID: PMC4894759          DOI: 10.1097/MOP.0000000000000355

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  48 in total

Review 1.  Cardiopulmonary changes with aeration of the newborn lung.

Authors:  Stuart Brian Hooper; Graeme Roger Polglase; Charles Christoph Roehr
Journal:  Paediatr Respir Rev       Date:  2015-03-17       Impact factor: 2.726

2.  STARTS-2: long-term survival with oral sildenafil monotherapy in treatment-naive pediatric pulmonary arterial hypertension.

Authors:  Robyn J Barst; Maurice Beghetti; Tomas Pulido; Gary Layton; Irina Konourina; Min Zhang; D Dunbar Ivy
Journal:  Circulation       Date:  2014-03-17       Impact factor: 29.690

3.  Clinical features of paediatric pulmonary hypertension: a registry study.

Authors:  Rolf M F Berger; Maurice Beghetti; Tilman Humpl; Gary E Raskob; D Dunbar Ivy; Zhi-Cheng Jing; Damien Bonnet; Ingram Schulze-Neick; Robyn J Barst
Journal:  Lancet       Date:  2012-01-11       Impact factor: 79.321

4.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.

Authors:  W H Northway; R C Rosan; D Y Porter
Journal:  N Engl J Med       Date:  1967-02-16       Impact factor: 91.245

5.  Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.

Authors:  Peter M Mourani; Marci K Sontag; Adel Younoszai; Joshua I Miller; John P Kinsella; Christopher D Baker; Brenda B Poindexter; David A Ingram; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

Review 6.  Pulmonary vascular development goes awry in congenital lung abnormalities.

Authors:  Heleen Kool; Daphne Mous; Dick Tibboel; Annelies de Klein; Robbert J Rottier
Journal:  Birth Defects Res C Embryo Today       Date:  2014-11-26

7.  VEGF is deposited in the subepithelial matrix at the leading edge of branching airways and stimulates neovascularization in the murine embryonic lung.

Authors:  A M Healy; L Morgenthau; X Zhu; H W Farber; W V Cardoso
Journal:  Dev Dyn       Date:  2000-11       Impact factor: 3.780

8.  Sildenafil Treatment of Infants With Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.

Authors:  Carl H Backes; Patricia B Reagan; Charles V Smith; Sudarshan R Jadcherla; Jonathan L Slaughter
Journal:  Hosp Pediatr       Date:  2015-01-01

9.  Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease.

Authors:  Peter M Mourani; Marci K Sontag; Adel Younoszai; D Dunbar Ivy; Steven H Abman
Journal:  Pediatrics       Date:  2008-02       Impact factor: 7.124

10.  Use of inhaled nitric oxide in preterm infants.

Authors:  Praveen Kumar
Journal:  Pediatrics       Date:  2013-12-30       Impact factor: 7.124

View more
  6 in total

1.  Evidence of Echocardiographic Markers of Pulmonary Vascular Disease in Asymptomatic Infants Born Preterm at One Year of Age.

Authors:  Philip T Levy; Meghna D Patel; Swati Choudhry; Aaron Hamvas; Gautam K Singh
Journal:  J Pediatr       Date:  2018-04-03       Impact factor: 4.406

2.  Pulmonary hypertension in the premature infant population: Analysis of echocardiographic findings and biomarkers.

Authors:  Michael G O'Connor; Divya Suthar; Kimberly Vera; James C Slaughter; Natalie L Maitre; Steven Steele; Amy Beller; Candice D Fike; Judy L Aschner; Paul E Moore; Eric D Austin
Journal:  Pediatr Pulmonol       Date:  2017-11-23

3.  The Effect of Preterm Birth on Maximal Aerobic Exercise Capacity and Lung Function in Healthy Adults: A Systematic Review and Meta-analysis.

Authors:  Thomas Gostelow; Eric J Stöhr
Journal:  Sports Med       Date:  2022-06-27       Impact factor: 11.928

4.  DDAH1 regulates apoptosis and angiogenesis in human fetal pulmonary microvascular endothelial cells.

Authors:  Jennifer K Trittmann; Hanadi Almazroue; Yi Jin; Leif D Nelin
Journal:  Physiol Rep       Date:  2019-07

5.  Pulmonary Function Tests in Very Low Birth Weight Infants Screened for Pulmonary Hypertension: A Pilot Study.

Authors:  John D Adair; Brendan Kelly; Diane Schilling; Kseniya Parkhotyuk; Ladawna Gievers; Amanda Kim; Brian Scottoline; Cindy T McEvoy
Journal:  J Pediatr       Date:  2021-06-25       Impact factor: 6.314

6.  Initial Experience With Patent Ductus Arteriosus Ligation in Pre-term Infants With Bidirectional Shunt Pattern.

Authors:  Ming-Chun Yang; Hsien-Kuan Liu; Hsuan-Yin Wu; Shu-Leei Tey; Yung-Ning Yang; Chien-Yi Wu; Jiunn-Ren Wu
Journal:  Front Pediatr       Date:  2020-10-26       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.